External coating agent composition for treating insomnia

Abstract

The invention provides an external coating agent composition for treating insomnia. The external coating agent composition comprises a plaster composition agent A prepared from poria with hostwood, fossil fragments and the like, a plaster composition agent B prepared from radix scrophulariae, radix rehmanniae and the like, and a powder composition agent C prepared from jasmine roots, pepper, dogwood and the like. The ingredients are common pure traditional Chinese medicine; the composition agent A and the composition agent B are used for preparing plaster to be attached to the Yongquan acupoint of the sole and the navel; composition agent C powder is used for external foot soaking; no toxic and side effects exist; the effects of tranquilizing and allaying excitement are achieved; a good curative effect is achieved on insomnia treatment; safety and reliability are realized; the use is convenient; no side effect exists; the external coating agent composition can be used for a long time and is almost ideal traditional Chinese medicine composition for treating insomnia.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to an external coating composition for treating insomnia. Background technique [0002] Insomnia is a common health problem in modern people. The common symptoms are difficulty in falling asleep, decreased sleep quality and sleep time, decreased memory and attention. In 2012, the Sleep Disorders Group of the Chinese Medical Association Neurology Branch based on existing evidence Based on medical evidence, the "Guidelines for the Diagnosis and Treatment of Insomnia in Chinese Adults" was formulated, in which insomnia refers to a subjective experience of patients who are not satisfied with sleep time and (or) quality and affect daytime social function. [0003] In modern medicine, interventions for insomnia mainly include drug treatment and non-drug treatment. That is, for patients with acute insomnia, drug therapy should be applied early; for patients...

AI Technical Summary

Problems solved by technology

That is, for patients with acute insomnia, drug therapy should be applied early; for patients with subacute or chronic insomnia, no matter whether it is primary or secondary, psychological and behavioral therapy should be supplemented with drug therapy, even those who have been taking sedative-hypnotic drugs for a long time The same is true for insomnia patients. The effective psychobehavioral treatment for insomnia is mainly cognitive behavioral therapy, and drug intervention occupies a dominant position in insomnia treatment. In addition to psychobehavioral therapy, other non-drug treatments, such as diet therapy, aromatherapy, massage, Homeopathy, light therapy, etc. lack convincing large-sample controlled studies